Do You Lose More Weight on Wegovy or Mounjaro? A Comprehensive Comparison

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Two leading GLP-1 receptor agonists dominate the weight loss conversation: semaglutide and tirzepatide. While both medications reduce hunger and promote sustainable weight loss, tirzepatide activates an additional hormone pathway (GIP) that may drive stronger metabolic changes. Understanding how each works helps you make an informed choice about your personalized treatment plan.

How Semaglutide and Tirzepatide Work Differently in Your Body

Semaglutide activates GLP-1 receptors throughout your digestive system and brain, slowing stomach emptying and increasing feelings of fullness after smaller meals. This single-pathway mechanism has proven effective for sustained weight loss over time. The medication signals your pancreas to release insulin when blood sugar rises, naturally stabilizing appetite cues.

Tirzepatide engages two separate hormone pathways simultaneously: GLP-1 and GIP receptors. This dual activation targets your body's metabolic machinery from multiple angles. By stimulating glucose-dependent insulin secretion and reducing liver glucose production, tirzepatide addresses weight loss through broader biochemical mechanisms than single-pathway drugs.

Clinical Trial Data: Weight Loss Outcomes Compared

Semaglutide users in major clinical trials achieved average weight loss between 10% and 16% of body weight over 68 weeks at the highest tested doses. These results represent meaningful improvements for people managing obesity and type 2 diabetes. The medication's effects appear consistent across different age groups and baseline weights.

Tirzepatide demonstrated more pronounced weight loss in parallel trials, with participants losing 21% to 22% of body weight at the highest doses over similar timeframes. The additional GIP pathway activation appears responsible for this stronger metabolic response. However, individual variation remains significant—some patients respond equally well to semaglutide depending on their genetic predispositions and tolerance to dose escalation.

Side Effects and Tolerability: What Matters for Long-Term Success

Both medications commonly cause gastrointestinal effects like nausea, vomiting, and constipation, particularly during dose increases. Semaglutide users often report these effects diminish within two to four weeks as their body adjusts. The slower titration schedule for semaglutide may help some people tolerate the medication more comfortably over time.

Tirzepatide's stronger dual-pathway activation can produce more pronounced initial side effects in some patients. Nausea and appetite suppression may feel more intense during the first month. However, many users find these effects manageable and diminishing as they progress through their dose escalation protocol. Your individual genetic profile influences how your GLP-1 and GIP receptors respond to activation.

Cost, Access, and Personalized Treatment Through PlexusDx

PlexusDx offers compounded semaglutide injections starting at $149 per month and compounded tirzepatide injections starting at $249 per month through licensed 503A compounding pharmacies. Both medications remain available across all 50 states without insurance requirements or membership fees. Your dose may need to go up. Your price won't—PlexusDx maintains consistent monthly pricing regardless of your dose progression.

The Precision Peptide Genetic Test ($99 add-on after your first month) maps your genetic variants across 14 metabolic pathways and 49 peptides, revealing which therapy aligns with your biological predispositions. Testing for variants like GLP1R rs6923761 and GIPR rs1800437 helps predict your likely response to single-pathway versus dual-pathway activation. This personalized approach removes guesswork from selecting between semaglutide and tirzepatide.

Which Medication Should You Choose?

Choose semaglutide if you prefer a single-pathway approach, tolerate slower dose escalation better, or have had positive responses to GLP-1 therapy previously. Semaglutide also represents a lower entry point financially while still delivering clinically significant weight loss. Many patients succeed with semaglutide for years, maintaining steady metabolic improvements without needing higher-powered compounds.

Choose tirzepatide if you need more aggressive metabolic activation, haven't responded adequately to GLP-1 monotherapy, or have genetic markers favoring GIP-pathway sensitivity. Tirzepatide's dual mechanism offers greater average weight loss, making it particularly valuable for people with substantial weight to lose or metabolic resistance. PlexusDx providers can help you start with either medication and adjust based on your real-world response.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I lose more weight on tirzepatide than semaglutide?

Clinical trials show tirzepatide produces approximately 5-7% greater average weight loss than semaglutide at comparable timepoints. However, individual results vary significantly based on genetics, adherence, lifestyle, and dose tolerance. Some patients achieve excellent results with semaglutide alone, while others benefit from tirzepatide's dual-pathway activation. PlexusDx genetic testing can help identify which mechanism aligns with your metabolic profile.

Can I switch from semaglutide to tirzepatide if I'm not seeing results?

Yes, switching between medications is safe and relatively common in precision weight loss treatment. If you've plateaued on semaglutide after reaching a stable dose, tirzepatide's additional GIP-pathway activation may reignite weight loss. PlexusDx providers monitor your progress and can recommend switching if clinical indicators suggest a better fit, ensuring continuous improvement toward your goals.

How much do semaglutide and tirzepatide cost at PlexusDx?

PlexusDx compounded semaglutide injections start at $149 per month, while compounded tirzepatide injections start at $249 per month. Both are available through licensed 503A compounding pharmacies across all 50 states without insurance or membership requirements. Your pricing remains flat regardless of dose increases—your dose may need to go up, but your price won't.

Which medication causes fewer side effects?

Semaglutide's single-pathway mechanism may produce milder initial nausea for some patients, particularly with its slower titration schedule. Tirzepatide's stronger dual activation can feel more intense early on but typically improves within weeks. Individual side effect experiences depend more on your genetics, dose tolerance, and body composition than the medication itself. Both are generally well-tolerated long-term.

Can genetic testing predict which medication will work better for me?

PlexusDx Precision Peptide Genetic Test identifies your variants in GLP1R, GIPR, FTO, and MC4R pathways, revealing how your body likely responds to GLP-1 and GIP activation. These 150+ genetic insights help predict which medication mechanism—single or dual pathway—aligns with your biology. Testing isn't required to start treatment, but adding it after your first month provides personalized guidance for optimizing your therapy.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Mounjaro For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.